Children and teens with ADHD have varying needs for control of symptoms throughout their day. The development of the methylphenidate transdermal patch, Daytrana, Shire Pharmaceuticals, has been a great advance in improved coverage and control of ADHD symptoms. The dose of this methylphenidate patch was studied in a recent Journal of the American Academy […]
Read More →This is the final series of articles addressing ADHD. The research community in the 1990s became aware that children who were diagnosed with ADHD as youngsters generally continued to be ADHD as adults. In fact, we now know that over eighty percent of children continue to be diagnosed with ADHD as adults. The understanding, […]
Read More →Fragile X syndrome is the most commonly known cause of inherited developmental disability. It is estimated that it occurs one in every 2000 – 5000 live births. Fragile X is caused by mutations in a gene on part of the X chromosome, which leads to abnormal brain development. This disability also accounts for six […]
Read More →Our article in March gave a brief history of ADHD. Understanding of the causes and treatment of ADHD continued in the 1930’s. Charles Bradley began using stimulant medication to a group of hyperactive children. Using amphetamines, he noted dramatic improvement in the children’s conduct and school performance. This work was rediscovered in the […]
Read More →Is ADHD a “new” diagnosis, the result of our modern, hurried, technologically driven society?. In the early 1800’s, ADHD was first noted by researchers who recognized that some patients recovering from serious head trauma often presented with overactive, impulsive inattentive and distractible behavior. There was decisive great increase in the activity level and mood […]
Read More →